Sign In
Buy HRMY
$35.24
-0.620 (-1.73%)
At Close: Jul 31, 2026
Harmony Biosciences Launches Grant Program To Address Inequities In The Delivery Of Healthcare In Patients With Sleep Disorders
08:05am, Wednesday, 07'th Apr 2021
PLYMOUTH MEETING, Pa., April 7, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative t
4 New Standout Stocks From Goldman Sachs Analysts
12:08pm, Monday, 29'th Mar 2021
Analysts at Goldman Sachs are out with four new Buy recommendations on companies in the oil, biotech and health care businesses.
Harmony Biosciences Hosts Summit Which Sheds Light on Impact of Sleep Disruption in Rare Diseases
08:05am, Friday, 19'th Mar 2021
PLYMOUTH MEETING, Pa., March 19, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative t
Harmony Biosciences Highlights Publication of WAKIX® (pitolisant) Efficacy Data in Sleep Medicine
08:05am, Wednesday, 17'th Mar 2021
PLYMOUTH MEETING, Pa., March 17, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative the
Harmony Biosciences Appoints Sandip Kapadia as Chief Financial Officer
08:05am, Monday, 15'th Mar 2021
PLYMOUTH MEETING, Pa., March 15, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative th
PLYMOUTH MEETING, Pa. and CHICAGO, Dec. 15, 2020 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing inn
Harmony Biosciences Appoints Mark Graf And Eric Motley To Its Board Of Directors
05:00pm, Wednesday, 11'th Nov 2020
PLYMOUTH MEETING, Pa. and CHICAGO, Nov. 11, 2020 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing inn
Harmony Biosciences Announces Date Of Third Quarter 2020 Financial Results
08:05am, Wednesday, 28'th Oct 2020
PLYMOUTH MEETING, Pa. and CHICAGO, Oct. 28, 2020 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing inn
U.S. IPO Week Ahead: The IPO Market Braces For A September SNOWstorm In A 12-IPO Week
11:07am, Sunday, 13'th Sep 2020
The post-Labor Day IPO frenzy is here as 12 IPOs plan to raise $6.8 billion in the coming week, led by cloud data unicorn Snowflake.
U.S. IPO Weekly Recap: Biotechs And SPACs Ride The Summer Wave In A 4 IPO Week
06:48am, Sunday, 23'rd Aug 2020
Three drug developers and a medical imaging company went public this past week, joined by eight SPACs. The week's eight SPAC IPOs raised $3.3 billion.
Harmony Biosciences: Interesting Pharmaceutical Public Offering
05:47am, Thursday, 20'th Aug 2020
Harmony Biosciences is an interesting biopharmaceutical company, as its only approved product is showing rapid growth coming out of the gate.
U.S. IPO Week Ahead: The IPO Market's Summer Slowdown Approaches In A 3-IPO Week
03:41pm, Saturday, 15'th Aug 2020
Two biotechs, a medical imaging company, and two SPACs are scheduled to go public in the week ahead. Another biotech, Kymera Therapeutics, is eligible to launch.
Stocks To Watch: Walmart, Target, Kandi And Gold vs. Bitcoin
08:30am, Saturday, 15'th Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Harmony Biosciences Starts U.S. IPO Effort
12:23pm, Friday, 31'st Jul 2020
Harmony Biosciences has filed to raise $100 million in an IPO, although the final figure will likely differ.
